Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02239068 · ClinicalTrials.gov registry record
CT Residual Gastric Fluid Volume
A clinical trial of Clinical CT Abdomen/Pelvic With Oral Contrast and Sedation, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- 76
- Enrollment target
- 1
- Study location
NCT02239068: Completed study of Clinical CT Abdomen/Pelvic With Oral Contrast and Sedation, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT02239068 is a study of Clinical CT Abdomen/Pelvic With Oral Contrast and Sedation that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 76 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02239068, a study of Clinical CT Abdomen/Pelvic With Oral Contrast and Sedation, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- 76 participants
- Enrollment target
- 1
- Study location
Study Summary
Hypothesis: The investigators hypothesize that more than 50% of the patients receiving enteric contrast material (ECM) \< 2 hours of anesthesia/sedation would have residual gastric fluid volume (GFV) \> 0.4 ml/kg. The investigators also hypothesize that measuring GFV by using region of interest in the CT technique is accurate compared to blind aspiration of the gastric contents with a syringe and a multi-orificed orogastric tube.
Primary Outcome
Patients will have gastric volume suctioned and measured after the CT scan. The investigator will compare the amount suctioned to the measurement from the actual CT scan when all patients have been enrolled in the study.
Conditions Studied
Study Locations (1)
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2011-06-28 |
| Est. Completion | 2023-06-01 |
What the finished NCT02239068 record still lists
NCT02239068 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 76 participants, a relatively small participant target.
The record links to 1 condition, with Clinical CT Abdomen/Pelvic With Oral Contrast and Sedation appearing as the primary indexed condition, and to 0 interventions.
NCT02239068 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT02239068 about?
NCT02239068 is a clinical study titled "CT Residual Gastric Fluid Volume". Hypothesis: The investigators hypothesize that more than 50% of the patients receiving enteric contrast material (ECM) \< 2 hours of anesthesia/sedation would have residual gastric fluid volume (GFV) \> 0.4 ml/kg. The investigators also hypothesize that measuring GFV by using region of interest in t...
What is the current status of trial NCT02239068?
This trial is currently completed. The enrollment target is 76 participants. The study started on 2011-06-28. Estimated completion is 2023-06-01.
What conditions does trial NCT02239068 study?
This clinical trial studies the following conditions: Clinical CT Abdomen/Pelvic With Oral Contrast and Sedation.
Who is sponsoring clinical trial NCT02239068?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02239068 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02615184 · 76 participants · Phase 2
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
- NCT02821741 · 76 participants · NA
Effects of External Ear Stimulation on Pain Perception and Mood
- NCT03019757 · 76 participants
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- NCT03353584 · 76 participants · NA
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI